TORONTO DOMINION BANK - ZOMEDICA PHARMACEUTICALS COR ownership

ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 6 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TORONTO DOMINION BANK ownership history of ZOMEDICA PHARMACEUTICALS COR
ValueSharesWeighting
Q3 2020$0200.0%0.00%
Q2 2020$0200.0%0.00%
Q1 2020$0200.0%0.00%
Q4 2019$020
-92.2%
0.00%
Q3 2019$0255
-39.6%
0.00%
Q2 2019$0422
+421.0%
0.00%
Q1 2019$0810.0%0.00%
Q4 2018$0810.0%0.00%
Q3 2018$081
+118.9%
0.00%
Q2 2018$037
+85.0%
0.00%
Q1 2018$0200.0%0.00%
Q4 2017$0200.00%
Other shareholders
ZOMEDICA PHARMACEUTICALS COR shareholders Q4 2020
NameSharesValueWeighting ↓
Cambridge Investment Research Advisors, Inc. 12,079,080$22,588,0000.22%
jvl associates llc 58,500$109,0000.10%
Sigma Planning Corp 26,642$50,0000.00%
TCI Wealth Advisors, Inc. 180$00.00%
BANK OF AMERICA CORP /DE/ 2,142$4,0000.00%
WELLS FARGO & COMPANY/MN 11,295$21,0000.00%
NORTHERN TRUST CORP 353,334$660,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 13,172$25,0000.00%
Legal & General Group Plc 5,852$11,0000.00%
View complete list of ZOMEDICA PHARMACEUTICALS COR shareholders